Manufacturers Consider Design Changes For OTC Propylhexedrine Nasal Decongestant Inhalers
Executive Summary
"Manufacturers are already working on possible solutions to address the concerns and will work with the Agency to implement any appropriate measures,” says CHPA senior VP Barbara Kochanowski.